Health: New Treatment Discovered For Rare Eye Disease May Prevent Blindness
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine. Read on for details: